<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Moller P | Seppälä Lab</title><link>https://www.seppalalab.org/author/moller-p/</link><atom:link href="https://www.seppalalab.org/author/moller-p/index.xml" rel="self" type="application/rss+xml"/><description>Moller P</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Wed, 01 Jan 2025 00:00:00 +0000</lastBuildDate><image><url>https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.png</url><title>Moller P</title><link>https://www.seppalalab.org/author/moller-p/</link></image><item><title>Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequences</title><link>https://www.seppalalab.org/publication/moller-2025-colorectal/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/moller-2025-colorectal/</guid><description/></item><item><title>Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank</title><link>https://www.seppalalab.org/publication/moller-2025-commentary/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/moller-2025-commentary/</guid><description/></item><item><title>Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines</title><link>https://www.seppalalab.org/publication/cavestro-2023-delphi/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/cavestro-2023-delphi/</guid><description/></item><item><title>Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement</title><link>https://www.seppalalab.org/publication/moller-2023-dominantly/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/moller-2023-dominantly/</guid><description/></item><item><title>Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/</guid><description/></item><item><title>Response to Chambuso et al</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2022-response/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2022-response/</guid><description/></item><item><title>Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2021-analysis/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2021-analysis/</guid><description/></item><item><title>European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender</title><link>https://www.seppalalab.org/publication/seppala-2021-european/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2021-european/</guid><description/></item><item><title>No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2021-no/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2021-no/</guid><description/></item><item><title>Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)</title><link>https://www.seppalalab.org/publication/seppala-2021-prospective/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2021-prospective/</guid><description/></item><item><title>Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2021-risk-reducing/</guid><description/></item><item><title>The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance</title><link>https://www.seppalalab.org/publication/ahadova-2021-the/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/ahadova-2021-the/</guid><description/></item><item><title>Towards evidence-based personalised precision medicine for Lynch syndrome</title><link>https://www.seppalalab.org/publication/moller-2021-towards/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/moller-2021-towards/</guid><description/></item><item><title>Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report</title><link>https://www.seppalalab.org/publication/seppala-2021-uptake/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2021-uptake/</guid><description/></item><item><title>Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2020-cancer/</guid><description/></item><item><title>Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2020-correction/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2020-correction/</guid><description/></item><item><title>Response to Tolva et al</title><link>https://www.seppalalab.org/publication/sampson-2020-response/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/sampson-2020-response/</guid><description/></item><item><title>Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2020-risk-reducing/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2020-risk-reducing/</guid><description/></item><item><title>Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report</title><link>https://www.seppalalab.org/publication/seppala-2019-lack/</link><pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2019-lack/</guid><description/></item><item><title>Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report</title><link>https://www.seppalalab.org/publication/dominguez-valentin-2019-survival/</link><pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/dominguez-valentin-2019-survival/</guid><description/></item><item><title>Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database</title><link>https://www.seppalalab.org/publication/moller-2018-cancer/</link><pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/moller-2018-cancer/</guid><description/></item></channel></rss>